Publications

Found 6 results

2023
Tröster A, DiPrima M, Jores N, Kudlinzki D, Sreeramulu S, Gande SL, Linhard V, Ludig D, Schug A, Saxena K et al..  2023.  Optimization of the Lead Compound NVP-BHG712 as Colorectal Cancer Inhibitor. Chemistry - A European Journal.
2021
Sreeramulu S, Richter C, Berg H, Martin WMA, Ceylan B, Matzel T, Adam J, Altincekic N, Azzaoui K, Bains KJ et al..  2021.  Exploring the druggability of conserved RNA regulatory elements in the SARS-CoV-2 genome. Angew. Chem. Int. Ed. Engl.. 60:19191-19200.
2020
Binas O, de Jesus V, Landgraf T, Völklein AE, Martins J, Hymon D, Bains KJ, Berg H, Biedenbänder T, Fürtig B et al..  2020.  19F-NMR-based fragment screening for 14 different biologically active RNAs and 10 DNA and protein counter-screens. ChemBioChem.
Neuber C, Tröster A, Löser R, Belter B, Schwalbe H, Pietzsch J.  2020.  The Pyrazolo[3,4-d]pyrimidine-Based Kinase Inhibitor NVP-BHG712: Effects of Regioisomers on Tumor Growth, Perfusion, and Hypoxia in EphB4-Positive A375 Melanoma Xenografts.. Molecules. 25(21):E5115.
2019
DiPrima M, Wang D, Tröster A, Maric D, Terrades-Garcia N, Ha T, Kwak H, Sanchez-Martin D, Kudlinzki D, Schwalbe H et al..  2019.  Identification of Eph receptor signaling as a regulator of autophagy and a therapeutic target in colorectal carcinoma.. Mol. Oncol.. 13(11):2441-2459.
2018
Tröster A, Heinzlmeir S, Berger BT, Gande SL, Saxena K, Sreeramulu S, Linhard V, Nasiri AH, Bolte M, Müller S et al..  2018.  NVP-BHG712: Effects of regioisomers on the affinity and selectivity towards the EPHrin family. ChemMedChem. 13:2358-2464.